What is First Tracks Biotherapeutics Inc’s 1-month forecast?

Meyka AI projects TRAX could trade near $15.81 in the next month, a move of -56.37% compared to today’s price.

What is First Tracks Biotherapeutics Inc’s 1-year forecast?

By 2027, TRAX is forecasted to reach $41.05, reflecting a 13.28% change from the current level.

What is First Tracks Biotherapeutics Inc’s 5-year forecast?

The 2030 projection for TRAX is $269.88, which represents a potential 644.70% change.

What is the 7-year outlook for First Tracks Biotherapeutics Inc?

Over the next 7 years, TRAX could trade around $416.72, showing a 1049.89% move from today’s price.

Can First Tracks Biotherapeutics Inc (TRAX) reach $330 by 2030?

Meyka AI’s 2030 forecast places TRAX at $269.88, making it unlikely to reach $330 by 2030 under current market conditions.

First Tracks Biotherapeutics Inc (TRAX) Stock Forecast 2027, 2031 & 7-Year Price Prediction

Get the latest First Tracks Biotherapeutics Inc (TRAX) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

TRAX●NASDAQ

HealthcareBiotechnology

$36.24

$3.84(11.85%)

U.S. Market opens in 63h 32m

First Tracks Biotherapeutics Inc (TRAX)

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$15.81

Change↓ $-20.43 (-56.37%)

Quarterly Forecast

Predicted Price$40.49

Change↑ $4.25 (11.73%)

Yearly Forecast

Predicted Price$41.05

Change↑ $4.81 (13.28%)

3 Years Forecast

Predicted Price$156.72

Change↑ $120.48 (332.45%)

5 Years Forecast

Predicted Price$269.88

Change↑ $233.64 (644.70%)

7 Years Forecast

Predicted Price$416.72

Change↑ $380.48 (1049.89%)

First Tracks Biotherapeutics Inc Stock Forecast Summary

First Tracks Biotherapeutics Inc (TRAX) stock is currently priced at $36.24. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $15.81.

In the long term, TRAX shows a bullish trend. The 2027 forecast points to $41.05 (13.28% change), while the 2031 forecast suggests $269.88 (644.70% change). Looking 7 years ahead, projections estimate the stock could trade near $416.72, a 1049.89% change from today’s price.

Overall Sentiment

Neutral

Short-Term Outlook

Bearish

Long-Term Outlook

Bullish

This mix indicates that First Tracks Biotherapeutics Inc stock is expected to rise steadily over the coming years.

Investment Calculator

Estimate your potential returns on TRAX using our advanced Investment Calculator with AI-driven price forecasts. Enter your investment amount and select a target date to view expected results, including estimated profit, loss, and ROI performance.

Based on your investment of $1,000.00 in First Tracks Biotherapeutics Inc and holding until July 10th, 2027, you could face a potential +$132.84 profit, reflecting a +13.3% ROI over the next 365 days. These projections help you better understand short-term market movements.

Investment Amount (USD)

HODL Until?

$Shares Bought

27.5938

@ $36.24/share

~Forecast Price

$41.05

1-year AI forecast

$Est. Portfolio Value

$1,132.84

+$132.84 profit

%ROI

+13.3%

return on investment

First Tracks Biotherapeutics Inc yearly Price Forecast Chart

Explore the yearly forecast chart for TRAX, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate First Tracks Biotherapeutics Inc over different timeframes.

No forecast data available

No prediction data found for this time period.

Forecasting data is not available for TRAXForecasting details for TRAX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

First Tracks Biotherapeutics Inc Stock Forecast 2026

The forecast for First Tracks Biotherapeutics Inc (TRAX) in 2026 suggests a price of $41.05, representing a 13.28% move from today’s price.

Average Target: $41.05

Market Outlook: bullish based on current trend indicators.

Key Drivers in 2026:

Earnings growth projections.
Competitive performance in the Healthcare.
Macroeconomic factors such as interest rates and inflation.

First Tracks Biotherapeutics Inc Stock Forecast 2030

By 2030, Meyka AI projects TRAX could trade near $269.88, showing a potential 644.70% compared to current levels.

Average Target: $269.88

Market Outlook: bullish.

What could influence the 2030 forecast:

Technological innovation and product cycles.
Expansion into global markets.
Long-term investor sentiment toward First Tracks Biotherapeutics Inc.

First Tracks Biotherapeutics Inc 7-Year Stock Forecast (2032–2033)

Looking 7 years ahead, the long-term forecast for TRAX points to a price around $416.72, which is a projected 1049.89% move from today’s level.

Average Target: $416.72

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:

Global economic expansion or contraction.
Regulatory and policy environment.
First Tracks Biotherapeutics Inc’s ability to maintain market leadership.